Multidisciplinary assessment for supportive care in gynecological cancer patients
Impact of a Multidisciplinary Assessment in Day Hospitalization Versus Standard Care on the Deployment of Supportive Oncology Care Recommended by the Personalized Post-cancer Plan in Patients at the End of Initial Treatment for Gynecological Ovarian and Endometrial Cancer Endometrial Cancer
This study is testing whether a personalized care plan and support from a team of specialists can help women recovering from ovarian and endometrial cancers feel better compared to standard care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 268 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Centre Francois Baclesse Academic / other |
| Locations | 13 sites (Besançon and 12 other locations) |
| Trial ID | NCT06553612 on ClinicalTrials.gov |
What this trial studies
This project aims to enhance supportive oncology care for patients recovering from gynecological cancers, specifically ovarian and endometrial cancers. Patients will be divided into three groups based on their supportive care needs, with those requiring support randomized into two groups: one receiving a personalized post-cancer plan with a multidisciplinary assessment in a day hospital, and the other receiving standard care without day hospitalization. The study will also include an observational cohort for patients with no supportive care needs. The main goal is to effectively identify and manage the supportive oncology care needs of patients in remission.
Who should consider this trial
Good fit: Ideal candidates are women over 18 years old who are in remission from first-line treatment for endometrial or ovarian cancer.
Not a fit: Patients with locoregional or metastatic recurrence or those with associated medical or psychiatric conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of supportive care for patients recovering from gynecological cancers.
How similar studies have performed: Other studies have shown success with multidisciplinary approaches in supportive oncology care, indicating potential for positive outcomes in this context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient \> 18 years * Patients in remission from first-line treatment of endometrial or ovarian/tumor/peritoneal cancer. * Patient who has completed her initial treatment; patients on maintenance therapy are eligible. * Fluency in French * Patient with access to a telephone line * Patient affiliated to a social security scheme * Signature of informed consent prior to any specific study procedure Exclusion Criteria: * Any associated medical or psychiatric condition that could compromise the patient's ability to participate in the study * Patient with locoregional or metastatic recurrence * Patient deprived of liberty, under guardianship or curatorship * Simultaneous participation in a therapeutic clinical trial
Where this trial is running
Besançon and 12 other locations
- CHU, Besançon — Besançon, France (Recruiting)
- François Baclesse — Caen, France (Recruiting)
- Centre Jean Perrin — Clermont-Ferrand, France (Not_yet_recruiting)
- Centre Léon Bérard — Lyon, France (Recruiting)
- Hopital Diaconesses Croix Saint-Simon — Paris, France (Recruiting)
- Hopital Europeen George Pompidou — Paris, France (Not_yet_recruiting)
- Hôpital COCHIN — Paris, France (Not_yet_recruiting)
- Institut Curie — Paris, France (Not_yet_recruiting)
- Hopital privé des Côtes d'Armor — Plérin, France (Not_yet_recruiting)
- Institut Curie, St Cloud — Saint-Cloud, France (Recruiting)
- CHU, Saint Etienne — Saint-Etienne, France (Not_yet_recruiting)
- Chu — Strasbourg, France (Recruiting)
- Gustave Roussy — Villejuif, France (Recruiting)
Study contacts
- Study coordinator: Florence JOLY, Prof
- Email: f.joly@baclesse.unicancer.fr
- Phone: 02 31 45 50 50
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.